- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/02 - 1,2-OxazinesHydrogenated 1,2-oxazines
Patent holdings for IPC class C07D 265/02
Total number of patents in this class: 50
10-year publication summary
|
1
|
2
|
4
|
2
|
3
|
1
|
4
|
5
|
5
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1388 |
6 |
| Bayer Schering Pharma AG | 356 |
5 |
| Syngenta Crop Protection AG | 6321 |
4 |
| BioMarin Pharmaceutical Inc. | 385 |
4 |
| Adeka Corporation | 1370 |
3 |
| Nihon Nohyaku Co., Ltd. | 331 |
3 |
| Paratek Pharmaceuticals, Inc. | 117 |
3 |
| Novartis AG | 10500 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 669 |
2 |
| Abbott Laboratories | 2344 |
1 |
| Japan Science and Technology Agency | 1267 |
1 |
| Chlorion Pharma, Inc. | 3 |
1 |
| Enanta Pharmaceuticals, Inc. | 431 |
1 |
| FMC Corporation | 819 |
1 |
| Howard University | 196 |
1 |
| Kyowa Hakko Kirin Co., Ltd. | 279 |
1 |
| Mintz Levin Cohn Ferris Glovsky and Popeo PC | 11 |
1 |
| Nanjing Cavendish Bio-Engineering Technology Co., Ltd. | 15 |
1 |
| Promega Corporation | 578 |
1 |
| Sage Therapeutics, Inc. | 377 |
1 |
| Other owners | 7 |